NCT00652132 Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer Status COMPLETED Phase PHASE3
NCT00648648 A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001) Status COMPLETED Phase PHASE1
NCT00646659 Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00645632 Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma Status COMPLETED Phase NA
NCT00645593 Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00639769 Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00635726 Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer Status TERMINATED Phase PHASE2
NCT00632853 Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Status UNKNOWN Phase PHASE3
NCT00629863 Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer Status COMPLETED Phase NA
NCT00629226 Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00626639 A Study of Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT00625937 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT00625664 Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer Status COMPLETED Phase PHASE3
NCT00623558 Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) Status COMPLETED Phase PHASE2
NCT00623064 Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer Status COMPLETED Phase PHASE1
NCT00621361 Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients Status COMPLETED Phase PHASE1
NCT00620971 Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC Status COMPLETED Phase PHASE2
NCT00616785 Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Status UNKNOWN Phase PHASE2
NCT00614965 Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV Status COMPLETED Phase PHASE2